Sarcopenia and sarcopenic obesity after cholecystectomy: A population-based study

Da Gan,Xiaoyan Wang,Xiaochen Xu,Qingcong Kang,Zhonghua Lu,Menghan Jia,Yuan Ru,Xi He,Yun Mou,Wei He,Shankuan Zhu

DOI: https://doi.org/10.1002/oby.23334

IF: 9.298

2022-01-01

Obesity

Abstract:Objective The present study aimed to investigate the associations of cholecystectomy with low muscle mass, low muscle strength, sarcopenia, and sarcopenic obesity. Methods This population-based study included data from 4,909 participants aged 18 to 80 years. History of cholecystectomy was diagnosed using abdominal ultrasonography. Muscle mass was evaluated using a dual-energy x-ray absorptiometry scan, and muscle strength was evaluated using an electronic hand dynamometer. Sarcopenia was defined as the presence of both low muscle mass and low muscle strength. Sarcopenic obesity was defined as the presence of both sarcopenia and obesity. Multivariable logistic regression models were performed to investigate the associations of cholecystectomy with low muscle mass, low muscle strength, sarcopenia, and sarcopenic obesity. Results Participants with history of cholecystectomy were more likely than those without to have low muscle mass, low muscle strength, and sarcopenia. Furthermore, compared with cholecystectomy that occurred within 7 years (7 years is the median interval between cholecystectomy and the physical examination), participants with cholecystectomy that occurred more than 7 years ago had higher odds of sarcopenia. Finally, whether obesity was defined by BMI or body fat percentage, cholecystectomy was positively associated with sarcopenic obesity. Conclusions Cholecystectomy is associated with low muscle mass, low muscle strength, sarcopenia, and sarcopenic obesity.